Treatment with Mammalian Ste-20-like Kinase 1/2 (MST1/2) Inhibitor XMU-MP-1 Improves Glucose Tolerance in Streptozotocin-Induced Diabetes Mice

por Faizah, Zakiyatul, Amanda, Bella, Ashari, Faisal Yusuf, Triastuti, Efta, Oxtoby, Rebecca, Rahaju, Anny Setijo, Aziz, M. Aminudin, Lusida, Maria Inge, Oceandy, Delvac
Publicado 2020

Pharmacological inhibition of Hippo pathway, with the novel kinase inhibitor XMU‐MP‐1, protects the heart against adverse effects during pressure overload

por Triastuti, Efta, Nugroho, Ardiansah Bayu, Zi, Min, Prehar, Sukhpal, Kohar, Yulia Suciati, Bui, Thuy Anh, Stafford, Nicholas, Cartwright, Elizabeth J., Abraham, Sabu, Oceandy, Delvac
Publicado 2019

Micro RNA-411 Expression Improves Cardiac Phenotype Following Myocardial Infarction in Mice

por Nugroho, Ardiansah Bayu, Stafford, Nicholas, Zi, Min, Prehar, Sukhpal, Potter, Ryan, Kwon, Dowan, Kohar, Yulia Suciati, Triastuti, Efta, Bui, Thuy Anh, Cartwright, Elizabeth J., Oceandy, Delvac
Publicado 2022